Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumannii (Q39649372)

13 September 2017

Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii (English)

1 reference

13 September 2017

Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumannii (English)

1 reference

hospital-acquired infection

2 January 2024

main subject

Acinetobacter baumannii

1 reference

based on heuristic

inferred from title

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

Carl Urban

1

1 reference

13 September 2017

Sorana Segal-Maurer

2

1 reference

13 September 2017

James J. Rahal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746772

reference URL

2 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

13 September 2017

15 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12746772

reference URL

Clinical Infectious Diseases

2 January 2024

published in

1 reference

13 September 2017

36

1 reference

13 September 2017

10

1 reference

13 September 2017

1268-1274

1 reference

13 September 2017

1

1 reference

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

2 January 2024

2

1 reference

Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility

2 January 2024

3

1 reference

Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups

2 January 2024

4

1 reference

Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

2 January 2024

5

1 reference

Emerging carbapenemases in Gram-negative aerobes

2 January 2024

6

1 reference

Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii

2 January 2024

7

1 reference

Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance

2 January 2024

8

1 reference

Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing

2 January 2024

10

1 reference

Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa

2 January 2024

11

1 reference

Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites

2 January 2024

12

1 reference

Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam

2 January 2024

13

1 reference

Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases

2 January 2024

14

1 reference

Infection control in long-term care facilities

2 January 2024

15

1 reference

Feasibility of national surveillance of health-care-associated infections in home-care settings

2 January 2024

16

1 reference

The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally

2 January 2024

17

1 reference

Antibiotic resistance in the intensive care unit

2 January 2024

18

1 reference

The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients

2 January 2024

19

1 reference

Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii.

2 January 2024

20

1 reference

Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clini

2 January 2024

21

1 reference

Aerosol Polymyxin and Pneumonia in Seriously Ill Patients

2 January 2024

22

1 reference

Nebulized colistin causes chest tightness in adults with cystic fibrosis

2 January 2024

23

1 reference

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

2 January 2024

25

1 reference

Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.

2 January 2024

26

1 reference

Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.

2 January 2024

27

1 reference

A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein

2 January 2024

28

1 reference

Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii

2 January 2024

29

1 reference

In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak

2 January 2024

30

1 reference

Polymyxin B and Rifampin: New Regimen for Multiresistant Serratia marcescens Infections

2 January 2024

32

1 reference

Evaluation of different antibiotic actions combined with rifampicin. In vitro synergism against Pseudomonas and Proteus

2 January 2024

33

1 reference

Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary

2 January 2024

34

1 reference

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

2 January 2024

35

1 reference

Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam

2 January 2024

36

1 reference

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

2 January 2024

37

1 reference

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

2 January 2024

38

1 reference

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

2 January 2024

39

1 reference

Sulfamethoxazole-Trimethoprim-Polymyxin Therapy of Serious Multiply Drug-Resistant Serratia Infections

2 January 2024

40

1 reference

Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B.

2 January 2024

41

1 reference

Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol

2 January 2024

42

1 reference

2 January 2024

Identifiers

DOI

10.1086/374847

1 reference

13 September 2017

1 reference